Bioxytran (BIXT) FCF Margin (2010 - 2018)
Bioxytran (BIXT) reported FCF Margin of 0.02% for Q2 2018, up 8.63 percentage points from -8.61% a year earlier and up 0.63 percentage points from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) FCF Margin (2010 - 2018) Analysis & Trends
Over the twelve months ended Jun 30, 2018, Bioxytran's FCF Margin came in at 13.40%, up 24.58 percentage points year-over-year; for FY2017, it came in at -9.69%, up 7.51 percentage points from FY2016.
- FCF Margin has a five-year change of +10.66 percentage points (FY2012 to FY2017).
- By year, FCF Margin came in at -17.20% in FY2016 (-16.15 pp), -1.05% in FY2015 (+4.87 pp), -5.92% in FY2014 (-8.14 pp) and 2.22% in FY2013 (+22.57 pp).
- Five-year quarterly FCF Margin spans a low of -267.14% in Q3 2013 and a high of 21.25% in Q3 2017.
- Year over year, FCF Margin has now increased in each of the last five quarters, with an average year-over-year change of +13.75 percentage points over the last seven quarters.
- The high point for year-over-year FCF Margin in five years was Q3 2013 (a gain of 347.64 percentage points); the low point was Q2 2014 (a drop of 105.85 percentage points).
- Per Business Quant data, the three quarters before Q2 2018 came in at -0.60% (Q1 2018), 0.34% (Q4 2017) and 21.25% (Q3 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 0.02% |
| Mar 31, 2018 | -0.60% |
| Dec 31, 2017 | 0.34% |
| Sep 30, 2017 | 21.25% |
| Jun 30, 2017 | -8.61% |
| Mar 31, 2017 | -108.15% |
| Dec 31, 2016 | -13.20% |
| Sep 30, 2016 | -3.89% |
| Jun 30, 2016 | -21.10% |
| Mar 31, 2016 | -60.37% |
| Sep 30, 2015 | 19.45% |
| Jun 30, 2015 | -12.84% |
| Mar 31, 2015 | -5.50% |
| Sep 30, 2014 | 20.38% |
| Jun 30, 2014 | -122.79% |
| Mar 31, 2014 | 18.69% |
| Dec 31, 2013 | 2.88% |
| Sep 30, 2013 | -267.14% |
| Jun 30, 2013 | -16.94% |
| Mar 31, 2013 | 5.34% |
API Access
Bioxytran FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();